MBMudjiani Basuki

Mudjiani Basuki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mudjiani Basuki has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Depression Impact on Progressive Muscular Atrophy: A Rare Case Report of Motor Neuron Disease

    by Dina Faizatur Rahmah, Margarita Maria Maramis, Mudjiani Basuki, Elisabet Citra Dewi

    Progressive muscular atrophy (PMA) is a rare subtype of motor neuron disease (MND), accounting for approximately 2.5% of cases worldwide. It is characterized by progressive degeneration of lower motor neurons, leading to muscle atrophy, fasciculations, and weakness without early upper motor neuron involvement. Depression is a frequently reported psychiatric comorbidity in MND, yet may be difficult to recognize in PMA due to overlapping somatic symptoms and communication limitations in advanced disease. In this study, a 41-year-old man with progressive limb weakness initially attributed to cervical pathology, who was subsequently diagnosed with PMA and developed severe depressive symptoms during the advanced stage of illness with ventilator dependence, is reported. Psychiatric management included antidepressant therapy, supportive psychotherapy adapted to profound physical disability, and multidisciplinary care planning. This case highlights the diagnostic challenges of identifying depression in advanced PMA and illustrates the importance of integrated psychiatric care to address psychological distress, facilitate communication, and support decision-making. The report does not establish causal relationships but aims to contribute to the limited literature on psychiatric management in this rare condition.

  • Open Access

    Carpal Tunnel Syndrome (CTS) at the Neurology Clinic of Dr. Soetomo General Academic Hospital

    by Ratih Dewi Anggraini Jubair Hegemur, Fidiana Fidiana, Meisy Andriana, Mudjiani Basuki

    Highlight: CTS is a frequent peripheral neuropathy that causes a variety of debilitating symptoms, underscoring the importance of understanding its clinical characteristics for better diagnosis and treatment. The study conducted at the Neurology Clinic of Dr. Soetomo General Academic Hospital, Surabaya, highlights consistent patterns in CTS patient characteristics. This provides valuable insights into CTS demographics and symptoms, which may contribute to the development of effective management strategies. ABSTRACT Introduction: Carpal Tunnel Syndrome (CTS) is a common neuropathy of the upper extremities, with a higher prevalence in women, particularly those aged 40 to 60 years. It is characterized by compression of the median nerve within the carpal tunnel, most frequently caused by hypertrophy of surrounding synovial tissue or inflammatory responses from extensive wrist use or trauma. Clinical symptoms include pain, tingling, numbness, and weakness, which often worsen at night. Diagnosis is typically based on clinical evaluation using the Phalen and Tinel tests, and is confirmed by electromyography (EMG) and nerve conduction studies (NCS). Recognizing CTS traits is essential for accurate diagnosis and appropriate management, which motivated this study. Objective: To describe the characteristics of patients with CTS treated at the Neurology Clinic of Dr. Soetomo General Academic Hospital, Surabaya. Methods: This is a descriptive cross-sectional study conducted using secondary data collected between January 2019 and December 2020. The study used electronic medical records (EMRs), comprising 44 CTS cases that met the predefined criteria. Data were processed using statistical software. Results: Among the 44 patients diagnosed with CTS, the majority were aged 45-64 years (63.7%), and were predominantly women (88.6%), with housewives comprising the largest occupational group (29.5%). Paresthesia was the most reported symptom (97.7%), and hypertension was the most common comorbidity (92.9%). All patients received non-operative therapy (100%). Conclusion: This study revealed that CTS predominantly affects early elderly individuals, particularly women and housewives, with paresthesia as the main symptom and hypertension as the common comorbidity. Non-operative treatment was the primary management strategy, yielding insights for future therapeutic strategies.

  • Open Access

    Risk Factors and Complications in Herpes Zoster Patients at Dr. Soetomo General Academic Hospital, Surabaya

    by Shafa Karin Nadiva, Afif Nurul Hidayati, Mudjiani Basuki, Abdulloh Machin

    Highlights: Abstract Introduction: Herpes zoster (HZ) is a painful dermatomal rash caused by the reactivation of the varicella-zoster virus (VZV). Risk factors for HZ include age, gender, previous varicella infection, immunocompromised status, SARS-CoV-2 infection, and varicella vaccination. Complications include post-herpetic neuralgia (PHN), Ramsay Hunt syndrome, meningoencephalitis, vasculopathy, and varicella pneumonia. This study aimed to determine risk factors and complications in HZ patients and assist in improving prevention to reduce the prevalence of HZ patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Methods: This descriptive, retrospective study used secondary data from medical records of HZ patients at the Dermatology Clinic of Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, from 2019 to 2021. Statistical analysis was performed using the International Business Machines Corporation (IBM) Statistical Package for the Social Sciences (SPSS) version 25.0. Results: Among 105 cases, HZ was more prevalent in females (61 patients, 58.1%), with the highest incidence in the 46–55 years old age group (33 patients, 31.04%). The thoracic nerve was the most commonly affected (58 patients, 55.2%). Hypertension was the most common risk factor (26 patients, 24.7%), followed by diabetes mellitus/DM (15 patients, 14.3%) and autoimmune conditions (7 patients, 6.7%). Most patients had no comorbidities (33 patients, 31.4%). PHN was the most common complication (19 patients, 18.1%), while 78 patients (74.3%) experienced no complications. Conclusion: HZ was more prevalent among females, with hypertension being the most significant risk factor and PHN the most common complication.


  • Open Access

    Hubungan Antara Rasio H/M pada Stroke Akut dengan Derajad Spastisitas Pascastroke

    by Achmad Firdaus Sani, Yudhi Adrianto, Fadil, Fidiana, Mudjiani Basuki

    Pendahuluan: Spastisitas adalah gangguan motorik yang sering dijumpai dan muncul setelah stroke. Spastisitas dapat menyebabkan nyeri dan disabililitas pada bagian tubuh yang mengalaminya. Tujuan: mencari hubungan antara rasio H/M yang diukur dengan elektromiografi dengan derajad spastisitas yang terjadi setelah fase akut stroke. Metode: Penelitian ini adalah studi analisis korelatif observasional, dengan 26 sampel. Pasien diukur rasio H/M pada saat stroke akut dan diukur derajad spastisitasnya dengan menggunakan Modified Ashworth Scale setelah 3 bulan. Hasil yang didapatkan dilakukan analisa statistik dengan menggunakan tes korelatif kategorik dari Spearman. Hasil: Pasien yang mengikuti penelitian ini sebanyak 26 orang. Terdapat perbedaaan antara nilai H/M rasio antara sisi parese dengan sisi sehat dan tidak didapatkan hubungan yang bermakna antara nilai rasio H/M yang diukur saat fase akut stroke dengan derajad spastisitas yang diukur dengan Modified Ashworth Scale (MAS) setelah 3 bulan (p = 0,06 ; r = 0, 37). Kesimpulan: Rasio H/M pada pasien stroke akut meningkat pada sisi parese dibanding pada sisi sehat, namun peningkatan ini tidak memiliki hubungan yang signifikan dengan derajad spastisitas pasca stroke yang diukur dengan MAS, sehingga rasio H/M tidak dapat digunakan sebagai prediktor munculnya spastisitas pasca stroke


  • Open Access

    Hubungan antara Kadar HBA1C dengan Hasil Sural Radial Amplitude Ratio (SRAR) pada Pasien DM Tipe 1 dengan Neuropati Diabetik Perifer

    by Anny Hanifah, Mudjiani Basuki, Muhammad Faizi

    Pendahuluan: Neuropati diabetik perifer merupakan salah satu komplikasi mikroangiopati pada penderita diabetes mellitus. Manifestasi neuropati diabetik perifer paling banyak adalah polineuropati simetris distal, yang menunjukkan gangguan sensorik, motorik, serta penurunan refleks tendon dengan pola length-dependent. Diabetes Mellitus tipe 1 terbanyak diderita pada penderita usia muda, dimana saraf tepi memiliki amplitudo yang relatif masih tinggi, sehingga penurunan amplitudo yang relatif kecil, masih dianggap normal. Perbandingan amplitudo saraf sural dan radial dapat mendeteksi adanya neuropati subklinis. Penderita diabetes mellitus tipe 1 dengan kadar glukosa darah yang tidak teregulasi dengan baik mempunyai risiko 25.6% terkena neuropati diabetik perifer. Tujuan: untuk mengetahui hubungan antara kadar HbA1C dengan kejadian neuropati diabetik perifer pada penderita Diabetes Mellitus tipe 1. Metode: Penelitian ini merupakan penelitian observasional analitik dengan rancangan cross sectional dengan teknik pengambilan subjek penelitian menggunakan consecutive sampling admission yang memenuhi kriteria inklusi dan eksklusi. Subjek penelitian dilakukan pengukuran terhadap kadar HbA1C, amplitudo saraf sural dan radial dan dihitung perbandingan diantara keduanya. Hasil: Pada 38 subjek penelitian didapatkan 31 subjek penelitian dengan Sural Radial Amplitude Ratio (SRAR) rendah dan 7 subjek penelitian dengan nilai SRAR normal. Hasil analisis penelitian didapatkan bahwa pada subjek dengan nilai SRAR rendah lebih besar pada kelompok HbA1C tinggi yaitu 26 subjek (83.87%) dibandingkan dengan kelompok HbA1C normal yaitu 5 subjek (16.13%). Perbedaan tersebut bermakna secara statistik dengan p= 0.021, rasio odd 6.933 (IK 95% 1.173-40.981). Kesimpulan: Terdapat hubungan negatif antara kadar HbA1C dengan kejadian neuropati diabetik perifer pada penderita Diabetes Mellitus Tipe 1.


  • Open Access

    Mediastinal Anaplastic Ependymoma

    by Dyah Fauziah, Irene Lingkan Parengkuan, Dhihintia Jiwangga, Paulus Raharjo, Mudjiani Basuki

    Ependymomas arise from ependymal cells and can grow at any site in the central nervous system (CNS), as well as in some locations outside of the CNS. The latter is rare, contributing to the frequent misdiagnoses of such cases. Herein, we present the case of a 54-year-old man with a history of lower limb weakness and numbness. Magnetic resonance imaging revealed an extradural, heterogeneously enhanced solid lesion with a regular and well-defined border in the posterior mediastinum. A post-resection histopathological examination revealed tumor-forming perivascular pseudo-rosettes that showed immunoreactivity against glial fibrillary acidic protein, epithelial membrane antigen, and vimentin, as well as a high Ki-67 labeling index. Based on pathological features, a diagnosis of anaplastic ependymoma was established.

  • Mediastinal Anaplastic Ependymoma

    by Dyah Fauziah, Irene Lingkan Parengkuan, Dhihintia Jiwangga, Paulus Raharjo, Mudjiani Basuki

  • Open Access

    Updates in the management of Guillain Barre Syndrome

    by Novi Chandra, Fadil Baktir, Hanik Fidiana, Basuki Mudjiani, Hanik Hidayati

    Barré and Strohl in 1916. Although GBS has a good prognosis (5% mortality rate), about 10% of patients experience serious disability one year after the start of neurological onset. Recent research of GBS shows that the process involves a number of subtypes with different immunological mechanism and a spectrum of clinical syndrome of acute inflammatory neuropathy. Antibodies against peripheral nerve gangliosides and their own complements are recognized as an important mechanism of nerve damage in GBS. Pharmacokinetics of intravenous immunoglobulin (IVIg) therapy and other related factors that influence prognosis has been researched. In order to investigate the possible role of complement inhibition in GBS management, new studies will be conducted. The management of GBS should be provided in appropriate hospital units, with specialist teams, intensive care and rehabilitation facilities as essential parts. This article aims to provide updated management of GBS.Citation: Imelda NC, Baktir F, Fidiana, Hidayati HB, Basuki M. Updates in the management of Guillain Barre Syndrome. Anaesth Pain & Intensive Care 2018;22 Suppl 1:S54-S57


  • Open Access

    Management of peripheral neuropathy symptoms with a fixed dose combination of high-dose vitamin B1, B6 and B12: A 12-week prospective non-interventional study in Indonesia

    by Manfaluthy Hakim, Nani Kurniani, Rizaldy Taslim Pinzon, Dodik Tugasworo, Mudjiani Basuki, Hasmawi Haddani, Pagan Pambudi, Aida Fithrie, Audry Devisanty Wuysang

    Background: Peripheral neuropathy is a common condition which can have a significant impact on quality of life. It occurs as a component of several common and rare diseases or can be idiopathic and can present with various symptoms.Aims and Objectives: This study is aimed at evaluating the effectiveness and safety of the fixed dose combination of vitamin B1, B6 and B12in mild to moderate peripheral neuropathy of various etiologies in the Indonesian population.Materials and Methods: This was a prospective, open label, multi-center, single arm observational study (Indonesian Clinical Trial Registry No: INA-KPA0DYA). A total of 411 subjects with mild to moderate peripheral neuropathy of various etiologies, who met the eligibility criteria, were included in the study. A subject was considered to have “completed” the study if the study procedures, up to Visit 3 (one month of treatment) were accomplished. Procedural results and 12-week clinical outcomes are reported.Results: Treatment with combination of vitamin B1, B6 and B12 in subjects with symptoms of PN showed significant improvement in overall Total Symptom Score (TSS), within 14 days. The treatment also successfully reduced individual components of TSS from baseline to Visit 5. A significant percentage reduction was also observed for all the Visual Analogue Scale (VAS) parameters at the end of 12 weeks, while the Quality of Life (QoL) scores increased from baseline to the end of treatment.Conclusions: The fixed dose combination of vitamin B1, B6 and B12 was effective and welltolerated in subjects with mild to moderate peripheral neuropathy, of various etiologies.Asian Journal of Medical Sciences Vol.9(1) 2018 32-40